OVERVIEW

2023 Global Drug Bioavailability Enhancement Summit is organized by Curtis & Coulter LLC and will be held from May 16 - 17, 2023 at Princeton Marriott at Forrestal, Princeton, New Jersey, United States of America.

Description:
Connect with 160+ senior drug development innovators in Princeton, NJ this May for industry’s leading drug product development Summit. Attend and and uncover industry’s latest formulation and delivery technologies for improving drug product performance and bioavailability. Benefit from 30+ expert sessions and panels including:
• Targeted and Modified Delivery
• Model-Guided Formulation Design
• Nucleic Acid Delivery for Enabling MRNA
• Long-Acting Injectables – Biopharmaceutics & Product Design
• Rational Design of Oral Formulation
• Spray Conjealing to Enhance Bioavailability
• Advancing IVIVC of Subcutaneous Bioavailability
• MED 3D Printing for Oral Bioavailability
• Selection of Membrane-Permeable Peptides
• and many more sessions and panels
• Precision medicine & healthcare delivery
• Rationale formulation design for poorly soluble compounds
• In-vivo – in-vitro correlation
• Solution behavior of amorphous solid dispersions
• Nanosuspension for improving the bioavailability
• Early formulation screening in drug discovery
• 3D printing for biopharmaceuticals
• Enhancing patient adherence via drug delivery
• Innovative strategies around drug / device combinations
Additional details will be posted as soon as information is available.